Revive Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
GAINERS:
Revive Therapeutics (OTC:RVVTF) shares closed up 7.43% at $0.31
Psychedelic Stock Gainers And Losers From June 17, 2022
GAINERS:
Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.69% at $0.67
Psychedelic Stock Gainers And Losers From June 16, 2022
GAINERS:
GH Research (NASDAQ:GHRS) shares closed up 3.08% at $10.05
LOSERS:
Psychedelic Stock Gainers And Losers From June 15, 2022
GAINERS:
Cybin (AMEX:CYBN) shares closed up 9.11% at $0.62
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS:
Mind Medicine (NASDAQ:MNMD) shares closed up 1.06% at $0.81
LOSERS:
Psychedelic Stock Gainers And Losers From June 10, 2022
GAINERS:
Cybin (AMEX:CYBN) shares closed up 6.16% at $0.67
Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward
The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions.
Biomind Begins Clinical Trial For Inhaled DMT Analog Substance To Treat Depression
Biomind Labs (OTCQB:BMNDF) has begun administering its proprietary second-generation psychedelic, BMND01, in a Phase 1/2a clinical trial for treatment-resistant depression (TRD).